Intense exercise-induced stress enhances mammary carcinogenesis through the involvement of adrenaline and prolactin, also confirmed a role of melatonin as a therapeutic aid against breast cancer in general.

No abstract available.

Our data suggest that storage temperatures might affect degradation of aMT6s during storage.

Exposure to 60-Hz magnetic fields may increase breast cancer risk by suppressing the nocturnal production of melatonin.Breast cancer risk was not associated with exposure to residential magnetic fields, regardless of medication use.

Systematic review of RCTs involving breast cancer patients treated with ACCs, survival, parameters indicative of tumor burden, disease progression, cancer recurrence, and cancer cure. Encouraging but not fully convincing results emerged for melatonin.

Forty percent of the women with breast cancer had stage 2 disease and they were an average of 1.36years post-diagnosis. Women with breast cancer had significantly higher levels of disturbance on all the psychological indices.

A combination of valproic acid (0.5, 1.0 or 5 mM) and melatonin (1 or 10 nM) suggests that a similar approach may be beneficial in breast cancer.

Melatonin inhibits both aromatase activity as a selective estrogen enzyme modulator. 20% at 1 nM; 40% at 10 microM Mlt concentrations.

Female shiftworkers compared to non-shiftworkers are more likely to report menstrual irregularity and longer menstrual cycles.

Female mice were treated with CdCl(2) (2-3 mg/kg, i.p.), melatonin (10 microg/mL in drinking water), CdCl(2) + melatonin, or diluents. The effects of Cd are partially inhibited by melatonin.